Bristol-Myers Squibb - 46 Year Stock Price History | BMY

Historical daily share price chart and data for Bristol-Myers Squibb since 1972 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Bristol-Myers Squibb as of October 17, 2018 is 58.90.
Bristol-Myers Squibb Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2018 58.8453 60.0972 68.0535 50.1713 58.9000 -1.94%
2017 55.8849 56.7282 64.0573 44.9710 60.0678 7.72%
2016 59.7275 62.8154 72.7506 46.9761 55.7644 -13.50%
2015 59.6256 54.5035 65.9038 53.0736 64.4647 19.24%
2014 47.0314 46.5639 55.7953 41.7936 54.0639 14.18%
2013 38.3908 28.2613 47.6399 28.2613 47.3479 69.95%
2012 28.0372 28.7659 30.5928 26.3379 27.8595 -3.78%
2011 23.4098 20.8453 28.9959 19.8306 28.9549 39.43%
2010 19.7639 19.3845 21.6509 17.1747 20.7668 8.74%
2009 15.9029 17.0892 19.3917 12.5307 19.0971 14.78%
2008 14.9458 17.6559 18.2978 12.1866 16.6384 -6.05%
2007 18.9758 17.1250 21.2621 16.9432 17.7094 4.75%
2006 15.2353 14.2571 16.9066 12.8549 16.9066 19.93%
2005 14.6035 14.9113 15.8745 12.9014 14.0976 -6.16%
2004 14.4926 16.6259 17.3566 13.0402 15.0227 -7.27%
2003 13.9430 13.0339 16.2010 11.4610 16.2010 29.02%
2002 16.2625 26.4239 26.6577 10.8814 12.5566 -52.36%
2001 29.4084 36.2592 36.2592 25.3231 26.3567 -29.71%
2000 29.3223 32.1443 37.4966 21.7891 37.4966 17.11%
1999 33.8249 32.1061 38.8784 28.4718 32.0196 -2.80%
1998 26.6122 23.0487 32.9433 21.8747 32.9433 42.93%
1997 18.3755 12.7900 23.7261 12.7900 23.0487 77.07%
1996 10.7894 9.8212 13.7272 9.3077 13.0169 32.15%
1995 7.7886 6.5511 9.8785 6.4545 9.8499 53.27%
1994 6.0129 6.0554 6.6471 5.4070 6.4267 6.09%
1993 5.9677 6.6521 6.6521 5.2511 6.0575 -9.48%
1992 7.0096 8.4880 8.5361 6.1012 6.6918 -21.16%
1991 7.4895 6.2142 8.4880 5.7246 8.4880 35.84%
1990 5.3920 5.1065 6.2624 4.5889 6.2487 24.55%
1989 4.3425 3.8181 5.0701 3.7854 5.0169 28.87%
1988 3.6255 3.6802 3.9142 3.2760 3.8929 9.89%
1987 4.0584 3.5896 4.6800 3.1058 3.5424 0.78%
1986 3.2202 2.7974 3.7385 2.5689 3.5151 24.71%
1985 2.4935 2.1805 2.8769 2.1167 2.8187 26.48%
1984 1.9737 1.8350 2.2337 1.7763 2.2285 23.97%
1983 1.6519 1.4253 2.0265 1.3402 1.7976 25.65%
1982 1.2643 1.1221 1.5582 1.0877 1.4306 26.58%
1981 1.1135 1.0849 1.2445 0.9813 1.1302 5.46%
1980 0.8661 0.7739 1.0930 0.6541 1.0717 36.16%
1979 0.7350 0.7577 0.8137 0.6648 0.7871 3.50%
1978 0.7164 0.7101 0.8456 0.6010 0.7605 6.30%
1977 0.6929 0.7233 0.7577 0.6143 0.7154 -2.00%
1976 0.7777 0.7366 0.8802 0.6581 0.7300 -0.34%
1975 0.6605 0.5437 0.7831 0.5012 0.7325 37.38%
1974 0.4942 0.4973 0.5970 0.3363 0.5332 8.11%
1973 0.6504 0.7286 0.7592 0.4680 0.4932 -32.80%
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $94.525B $20.776B
Bristol-Myers Squibb is a differentiated company, led by their unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility of a biotech firm. They work every day to deliver innovative medicines for patients with serious and life-threatening diseases. Their employees around the world work together for patients - it drives everything they do. They are focused on helping millions of patients around the world in disease areas such as oncology, cardiovascular, immunoscience and fibrosis. Through their R&D organization, they have built a sustainable pipeline of potential therapies, and actively partner to access external innovation to broaden and accelerate their work.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $366.377B 17.18
Pfizer (PFE) United States $261.509B 15.31
Novartis AG (NVS) Switzerland $198.652B 17.04
Merck (MRK) United States $192.023B 16.96
AbbVie (ABBV) United States $139.177B 13.60
Eli Lilly (LLY) United States $119.245B 22.07
Sanofi (SNY) France $111.234B 14.08
Novo Nordisk (NVO) Denmark $106.025B 16.95
AstraZeneca (AZN) United Kingdom $98.986B 10.89
GlaxoSmithKline (GSK) United Kingdom $98.701B 13.18